Release Date: 26/02/14 16:02 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 25.99KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%